Page last updated: 2024-10-26

disulfiram and Peritoneal Neoplasms

disulfiram has been researched along with Peritoneal Neoplasms in 2 studies

Peritoneal Neoplasms: Tumors or cancer of the PERITONEUM.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Zhang, T1
Kephart, J1
Bronson, E1
Anand, M1
Daly, C1
Spasojevic, I1
Bakthavatsalam, S1
Franz, K1
Berg, H1
Karachaliou, GS1
James, OG1
Howard, L1
Halabi, S1
Harrison, MR1
Armstrong, AJ1
George, DJ1
Wang, P1
Luo, Q1
Zhang, L1
Qu, X1
Che, X1
Cai, S1
Liu, Y1

Trials

1 trial available for disulfiram and Peritoneal Neoplasms

ArticleYear
Prospective clinical trial of disulfiram plus copper in men with metastatic castration-resistant prostate cancer.
    The Prostate, 2022, Volume: 82, Issue:7

    Topics: Copper; Disulfiram; Humans; Male; Peritoneal Neoplasms; Prospective Studies; Prostatic Neoplasms, Ca

2022

Other Studies

1 other study available for disulfiram and Peritoneal Neoplasms

ArticleYear
A disulfiram/copper gluconate co-loaded bi-layered long-term drug delivery system for intraperitoneal treatment of peritoneal carcinomatosis.
    Colloids and surfaces. B, Biointerfaces, 2023, Volume: 231

    Topics: Animals; Cell Line, Tumor; Copper; Disulfiram; Drug Delivery Systems; Humans; Mice; Peritoneal Neopl

2023